{"id":"https://openalex.org/W7220850683","doi":"https://doi.org/10.1136/jsrd-2026-000041","title":"Novel clustering approach to understanding distinct phenotypes of patients with systemic sclerosis","display_name":"Novel clustering approach to understanding distinct phenotypes of patients with systemic sclerosis","publication_year":2026,"publication_date":"2026-07-01","ids":{"openalex":"https://openalex.org/W7220850683","doi":"https://doi.org/10.1136/jsrd-2026-000041","pmid":"https://pubmed.ncbi.nlm.nih.gov/42948250","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13711579"},"language":"en","primary_location":{"id":"doi:10.1136/jsrd-2026-000041","doi":"https://doi.org/10.1136/jsrd-2026-000041","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jsrd-2026-000041","pdf_url":null,"source":{"id":"https://openalex.org/S4210198508","display_name":"Journal of Scleroderma and Related Disorders","issn_l":"2397-1983","issn":["2397-1983","2397-1991"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","norway-1","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Scleroderma and Related Disorders","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1136/jsrd-2026-000041","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073269240","display_name":"Dinesh Khanna","orcid":"https://orcid.org/0000-0003-1412-4453","observed_orcids":["https://orcid.org/0000-0003-1412-4453"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]},{"id":"https://openalex.org/I4210114445","display_name":"Michigan Medicine","ror":"https://ror.org/01zcpa714","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210114445"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Dinesh Khanna","raw_affiliation_strings":["Department of Internal Medicine, University of Michigan Scleroderma Program, Ann Arbor, Michigan, USA"],"raw_orcid":"https://orcid.org/0000-0003-1412-4453","affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, University of Michigan Scleroderma Program, Ann Arbor, Michigan, USA","institution_ids":["https://openalex.org/I27837315","https://openalex.org/I4210114445"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112821984","display_name":"Mario Ehlers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mario Ehlers","raw_affiliation_strings":["Therapeutic Area Inflammation, Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, Connecticut, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Therapeutic Area Inflammation, Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, Connecticut, USA","institution_ids":["https://openalex.org/I4210160255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021458082","display_name":"Lizette Moros","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Lizette Moros","raw_affiliation_strings":["Therapeutic Area Inflammation, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Therapeutic Area Inflammation, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054329532","display_name":"Arpit Misra","orcid":"https://orcid.org/0000-0001-7767-4108","observed_orcids":["https://orcid.org/0000-0001-7767-4108"]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Arpit Misra","raw_affiliation_strings":["Therapeutic Area Mental and Eye Health, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Therapeutic Area Mental and Eye Health, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5137933553","display_name":"Hyemin Song","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Hyemin Song","raw_affiliation_strings":["Cross Therapeutic Area Marketing and Operations, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cross Therapeutic Area Marketing and Operations, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066633733","display_name":"Isabel Truman","orcid":"https://orcid.org/0000-0002-6055-2902","observed_orcids":["https://orcid.org/0000-0002-6055-2902"]},"institutions":[{"id":"https://openalex.org/I4210091464","display_name":"Adelphi Group (United Kingdom)","ror":"https://ror.org/00egpfv87","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210091464"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Isabel Truman","raw_affiliation_strings":["Adelphi Real World, Bollington, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adelphi Real World, Bollington, UK","institution_ids":["https://openalex.org/I4210091464"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064086075","display_name":"Liane Gillespie\u2013Akar","orcid":"https://orcid.org/0000-0002-5737-7592","observed_orcids":["https://orcid.org/0000-0002-5737-7592"]},"institutions":[{"id":"https://openalex.org/I4210091464","display_name":"Adelphi Group (United Kingdom)","ror":"https://ror.org/00egpfv87","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210091464"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Liane Gillespie-Akar","raw_affiliation_strings":["Adelphi Real World, Bollington, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adelphi Real World, Bollington, UK","institution_ids":["https://openalex.org/I4210091464"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5127472324","display_name":"Francesco Del Galdo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Francesco Del Galdo","raw_affiliation_strings":["University of Leeds, Leeds, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Leeds, Leeds, UK","institution_ids":["https://openalex.org/I130828816"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5073269240","https://openalex.org/A5127472324"],"corresponding_institution_ids":["https://openalex.org/I130828816","https://openalex.org/I27837315","https://openalex.org/I4210114445"],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":{"value":4150,"currency":"USD","value_usd":4150},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.76547459,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"11","issue":"2","first_page":"e000041","last_page":"e000041"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11330","display_name":"Systemic Sclerosis and Related Diseases","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11330","display_name":"Systemic Sclerosis and Related Diseases","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11310","display_name":"Connective tissue disorders research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13313","display_name":"Dupuytren's Contracture and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/clinical-subgroups","display_name":"clinical subgroups","score":0.8759999871253967},{"id":"https://openalex.org/keywords/latent-class-clustering","display_name":"latent class clustering","score":0.7929999828338623},{"id":"https://openalex.org/keywords/disease-severity","display_name":"disease severity","score":0.8759999871253967},{"id":"https://openalex.org/keywords/raynaud-s-phenomenon","display_name":"Raynaud's phenomenon","score":0.9100000262260437},{"id":"https://openalex.org/keywords/musculoskeletal-involvement","display_name":"musculoskeletal involvement","score":0.8899999856948853},{"id":"https://openalex.org/keywords/internal-organ-involvement","display_name":"internal organ involvement","score":0.9120000004768372},{"id":"https://openalex.org/keywords/disease-progression","display_name":"disease progression","score":0.6639999747276306},{"id":"https://openalex.org/keywords/time-to-diagnosis","display_name":"time to diagnosis","score":0.7369999885559082},{"id":"https://openalex.org/keywords/patient-treatment-preferences","display_name":"patient treatment preferences","score":0.574999988079071},{"id":"https://openalex.org/keywords/disease-burden","display_name":"disease burden","score":0.5019999742507935}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.694599986076355},{"id":"https://openalex.org/C164866538","wikidata":"https://www.wikidata.org/wiki/Q367351","display_name":"Cluster (spacecraft)","level":2,"score":0.6110000014305115},{"id":"https://openalex.org/C73555534","wikidata":"https://www.wikidata.org/wiki/Q622825","display_name":"Cluster analysis","level":2,"score":0.5975000262260437},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5730000138282776},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.5557000041007996},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.400299996137619},{"id":"https://openalex.org/C27415008","wikidata":"https://www.wikidata.org/wiki/Q7256382","display_name":"Psychological intervention","level":2,"score":0.3921999931335449},{"id":"https://openalex.org/C70727504","wikidata":"https://www.wikidata.org/wiki/Q1806878","display_name":"Latent class model","level":2,"score":0.3873000144958496},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.3702999949455261},{"id":"https://openalex.org/C2778674544","wikidata":"https://www.wikidata.org/wiki/Q1414805","display_name":"Systemic disease","level":3,"score":0.36399999260902405},{"id":"https://openalex.org/C3020646490","wikidata":"https://www.wikidata.org/wiki/Q25203551","display_name":"Clinical phenotype","level":4,"score":0.361299991607666},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3239000141620636},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.32249999046325684},{"id":"https://openalex.org/C195910791","wikidata":"https://www.wikidata.org/wiki/Q1324077","display_name":"Medical record","level":2,"score":0.2948000133037567},{"id":"https://openalex.org/C2779159551","wikidata":"https://www.wikidata.org/wiki/Q1414874","display_name":"Comorbidity","level":2,"score":0.2775000035762787},{"id":"https://openalex.org/C127716648","wikidata":"https://www.wikidata.org/wiki/Q104053","display_name":"Phenotype","level":3,"score":0.27469998598098755},{"id":"https://openalex.org/C2779075594","wikidata":"https://www.wikidata.org/wiki/Q8084905","display_name":"Autoimmune disease","level":3,"score":0.25920000672340393},{"id":"https://openalex.org/C205545832","wikidata":"https://www.wikidata.org/wiki/Q17156455","display_name":"Young adult","level":2,"score":0.2572000026702881},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.2508000135421753}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1136/jsrd-2026-000041","doi":"https://doi.org/10.1136/jsrd-2026-000041","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jsrd-2026-000041","pdf_url":null,"source":{"id":"https://openalex.org/S4210198508","display_name":"Journal of Scleroderma and Related Disorders","issn_l":"2397-1983","issn":["2397-1983","2397-1991"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","norway-1","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Scleroderma and Related Disorders","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13711579","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13711579/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13711579/pdf/jsrd-11-2.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Scleroderma Relat Disord","raw_type":"Text"},{"id":"pmid:42948250","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42948250","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of scleroderma and related disorders","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1136/jsrd-2026-000041","doi":"https://doi.org/10.1136/jsrd-2026-000041","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jsrd-2026-000041","pdf_url":null,"source":{"id":"https://openalex.org/S4210198508","display_name":"Journal of Scleroderma and Related Disorders","issn_l":"2397-1983","issn":["2397-1983","2397-1991"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","norway-1","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Scleroderma and Related Disorders","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320306257","display_name":"Boehringer Ingelheim","ror":"https://ror.org/05kffp613"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7220850683.pdf","grobid_xml":"https://content.openalex.org/works/W7220850683.grobid-xml"},"referenced_works_count":12,"referenced_works":["https://openalex.org/W2081741824","https://openalex.org/W2096382053","https://openalex.org/W2517885389","https://openalex.org/W2939397596","https://openalex.org/W3032942076","https://openalex.org/W3133194408","https://openalex.org/W4211001791","https://openalex.org/W4289593592","https://openalex.org/W4295941659","https://openalex.org/W4388461773","https://openalex.org/W4402035678","https://openalex.org/W4413872411"],"related_works":["https://openalex.org/W7163651147","https://openalex.org/W4392861026","https://openalex.org/W4289593592","https://openalex.org/W3045157308","https://openalex.org/W7163718004","https://openalex.org/W2417251675","https://openalex.org/W4411421833","https://openalex.org/W2939397596","https://openalex.org/W4389808107","https://openalex.org/W2953226909"],"abstract_inverted_index":{"Objectives:":[0],"Despite":[1],"earlier":[2,332],"clustering":[3,27,103],"studies":[4],"on":[5,141],"systemic":[6],"sclerosis":[7],"(SSc),":[8],"how":[9],"clinical":[10,31,145],"subgroups":[11],"differ":[12],"in":[13,116,235,250,254,261,265,278],"disease":[14,174,199,266],"burden,":[15,324],"treatment":[16,161,298],"and":[17,42,54,89,121,144,159,198,245,257],"patient-physician":[18],"dynamics":[19],"remains":[20],"unclear.":[21],"This":[22,125,307],"study":[23],"applied":[24],"a":[25,127,171,320],"novel":[26],"method":[28],"to":[29,150,300,322],"identify":[30],"subgroups.":[32],"Design:":[33],"Data":[34,59],"were":[35,60,222],"analysed":[36],"from":[37,81,297],"1906":[38],"adults":[39],"with":[40,176,187,216],"SSc":[41,74,312,323],"their":[43],"treating":[44],"rheumatologists":[45],"across":[46,163,288],"the":[47,73,82,117,205,241,269,292,304],"USA,":[48,83],"France,":[49,84],"Germany,":[50,85],"Italy,":[51,86],"Spain,":[52,87],"UK":[53,88],"Japan":[55],"(March-September":[56],"2022).":[57],"Setting:":[58],"collected":[61],"by":[62],"Adelphi":[63],"Real":[64],"World":[65],"as":[66,319],"part":[67],"of":[68,173,243,303,311,334],"an":[69],"independent":[70],"survey":[71],"titled":[72],"I":[75],"Disease":[76],"Specific":[77],"Programme,":[78],"comprising":[79,179],"data":[80],"Japan.":[90],"Participants:":[91],"Physicians":[92],"completed":[93,98],"case":[94],"record":[95],"forms;":[96],"patients":[97,186,287],"self-reported":[99],"questionnaires.":[100],"Latent":[101],"class":[102],"was":[104,126,138,204,232,274,299],"conducted":[105],"using":[106],"five":[107],"physician-reported":[108],"variables:":[109],"affected":[110,246],"body":[111,247],"areas,":[112],"symptoms,":[113],"severity,":[114,175],"flares":[115],"past":[118],"12":[119],"months":[120],"remission":[122],"status.":[123],"Interventions:":[124],"non-interventional,":[128],"observational,":[129],"retrospective":[130],"study.":[131],"Main":[132],"outcome":[133],"measures:":[134],"A":[135],"cluster":[136],"solution":[137],"selected":[139],"based":[140],"model":[142],"fit":[143],"interpretability.":[146],"We":[147,166],"compared":[148],"time":[149],"diagnosis,":[151,154],"symptoms":[152,218,244],"at":[153],"postdiagnosis":[155,273],"trajectories,":[156],"physician":[157],"management":[158],"patient":[160],"perspectives":[162],"clusters.":[164],"Results:":[165],"identified":[167],"four":[168],"clusters":[169,178,289],"representing":[170],"gradient":[172],"all":[177],">75%":[180],"females.":[181],"Clusters":[182,191,236,262,279],"1/2":[183,280],"comprised":[184],"younger":[185],"fewer":[188],"concomitant":[189],"conditions;":[190],"3/4":[192,282],"showed":[193],"greater":[194],"internal":[195],"organ":[196],"involvement":[197,231,317],"severity.":[200],"Raynaud's":[201],"phenomenon":[202],"(RP)":[203],"most":[206,233],"frequent":[207],"first":[208,217,270],"symptom":[209],"(physician-reported:":[210],"73%-85%;":[211],"patient-reported:":[212],"63%-79%),":[213],"but":[214],"those":[215],"other":[219],"than":[220],"RP":[221],"diagnosed":[223],"faster":[224],"(mean":[225],"1.06":[226],"vs":[227,281,284],"1.62":[228],"years).":[229],"Musculoskeletal":[230,316],"pronounced":[234],"2/4.":[237],"Postdiagnosis":[238],"(3.7-7.2":[239],"years),":[240],"number":[242],"areas":[248],"decreased":[249],"Cluster":[251,255],"1,":[252],"increased":[253],"4":[256],"remained":[258],"relatively":[259],"stable":[260],"2/3.":[263],"Improvement":[264],"progression":[267],"within":[268],"2":[271],"years":[272],"more":[275],"often":[276],"reported":[277,290],"(33%-34%":[283],"8%-20%).":[285],"Most":[286],"that":[291],"main":[293],"benefit":[294],"they":[295],"wanted":[296],"get":[301],"rid":[302],"disease.":[305],"Conclusions:":[306],"analysis":[308],"improves":[309],"understanding":[310],"beyond":[313],"limited/diffuse":[314],"subtypes.":[315],"emerged":[318],"contributor":[321],"supporting":[325],"its":[326],"integration":[327],"into":[328],"monitoring/stratification":[329],"strategies":[330],"for":[331],"identification":[333],"high-risk":[335],"patients.":[336]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-10-08T00:00:00"}